JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.72B |
| 2 |
Amazon
AMZN
|
+$2.99B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.6B |
| 4 |
Mastercard
MA
|
+$1.47B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.62B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.93B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.95% |
| 2 | Healthcare | 10.56% |
| 3 | Financials | 9.04% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
State Street SPDR S&P Software & Services ETF
XSW
$505M
| $5.52M | ﹤0.01% |
43,477
-594
| -1% | -$79.2K |
|
2652
Ardelyx
ARDX
$1.03B
| $5.51M | ﹤0.01% |
1,351,542
-14,819
| -1% | -$57.8K |
|
2653
Fate Therapeutics
FATE
$296M
| $5.5M | ﹤0.01% |
2,595,174
-133,469
| -5% | -$442K |
|
2654
Atlantic Union Bankshares
AUB
$6.14B
| $5.5M | ﹤0.01% |
190,958
+3,927
| +2% | +$117K |
|
|
DMC
2655
Del Monte Corp
DMC
$1.43B
| $5.49M | ﹤0.01% |
212,343
+95,812
| +82% | +$2.51M |
|
2656
Pebblebrook Hotel Trust
PEB
$2.06B
| $5.49M | ﹤0.01% |
403,723
-15,872
| -4% | -$228K |
|
2657
iQIYI
IQ
$1.29B
| $5.49M | ﹤0.01% |
1,157,237
-339,532
| -23% | -$1.77M |
|
2658
Tyra Biosciences
TYRA
$1.5B
| $5.48M | ﹤0.01% |
397,618
-25,803
| -6% | -$383K |
|
2659
Bank of Hawaii
BOH
$3.17B
| $5.47M | ﹤0.01% |
110,156
+24,004
| +28% | +$1.23M |
|
2660
PUT
Albemarle
ALB
$16.1B
| $5.46M | ﹤0.01% |
32,100
+5,400
| +20% | +$1.08M |
|
2661
PUT
Universal Display
OLED
$4.13B
| $5.45M | ﹤0.01% |
34,700
+22,500
| +184% | +$3.42M |
|
2662
ANI Pharmaceuticals
ANIP
$1.73B
| $5.45M | ﹤0.01% |
93,813
+2,601
| +3% | +$150K |
|
2663
PUT
Crocs
CROX
$6.35B
| $5.44M | ﹤0.01% |
61,700
+21,700
| +54% | +$2.23M |
|
2664
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
| $5.44M | ﹤0.01% |
83,387
-15,778
| -16% | -$1.06M |
|
2665
CALL
BP
BP
$110B
| $5.44M | ﹤0.01% |
140,400
+129,400
| +1,176% | +$4.8M |
|
2666
Movado Group
MOV
$797M
| $5.43M | ﹤0.01% |
198,465
+30,438
| +18% | +$828K |
|
|
DX
2667
Dynex Capital
DX
$3.25B
| $5.42M | ﹤0.01% |
454,014
-142,177
| -24% | -$1.8M |
|
2668
Blue Owl Capital
OWL
$19.3B
| $5.42M | ﹤0.01% |
418,140
+42,775
| +11% | +$510K |
|
|
INN
2669
Summit Hotel Properties
INN
$658M
| $5.41M | ﹤0.01% |
933,294
-1,490,081
| -61% | -$8.89M |
|
|
CBAY
2670
DELISTED
Cymabay Therapeutics
CBAY
| $5.41M | ﹤0.01% |
362,687
-60,774
| -14% | -$806K |
|
2671
Lumen
LUMN
$6.69B
| $5.4M | ﹤0.01% |
3,800,387
-9,451,880
| -71% | -$16M |
|
2672
CALL
AbbVie
ABBV
$441B
| $5.4M | ﹤0.01% |
36,200
+4,700
| +15% | +$690K |
|
2673
CALL
Royal Caribbean
RCL
$82.6B
| $5.38M | ﹤0.01% |
58,400
+40,400
| +224% | +$4.05M |
|
|
ICPT
2674
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.37M | ﹤0.01% |
289,771
+259,999
| +873% | +$2.94M |
|
2675
PUT
AT&T
T
$171B
| $5.37M | ﹤0.01% |
357,600
| – | – |
|
Similar funds
JP Morgan Chase's Q3 2023 Portfolio in Review
As of Q3 2023, JP Morgan Chase held 7,912 positions worth $906B, down 1.5% from $920B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
JP Morgan Chase's Q3 2023 filing shows 1,013 new, 2,454 increased, 3,092 reduced and 490 closed positions. Its largest new stake was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.62B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2023 buy was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M.
- JP Morgan Chase added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $3.72B increase.
- JP Morgan Chase's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.62B.
- JP Morgan Chase fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $314M.
- JP Morgan Chase's ten largest holdings make up 19% of its $906B portfolio in Q3 2023.
- JP Morgan Chase opened 1,013 new positions and closed 490 in Q3 2023.
- JP Morgan Chase's portfolio value fell 1.5% quarter-over-quarter to $906B.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.